Comparison of pharmacokinetics of clodronate after single and repeated doses

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 6, 1999, Pages 294-300

  Ylitalo, P ^a   Holli, K ^a   Monkkonen J ^b   Elo, H A ^b   Juhakoski, A ^c   Liukko Sipi, S ^c   Ylitalo, R ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Oy Leiras Finland Ab   (Finland)

Author keywords

Bisphosphonate; Clodronate; Drug dosage; Pharmacokinetics

Indexed keywords

CLODRONIC ACID;

ADULT; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXCRETION; DRUG MONITORING; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BONE NEOPLASMS; CLODRONIC ACID; CROSS-OVER STUDIES; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0032985996     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ala-Houhala I, Saha H, Liukko-Sipi S, Ylitalo P, Pasternack A 1998 Pharmacokinetics of clodronate in hemodialysis patients. Nephrol Dial Transplant in press
2. Castren-Kortekangas P, Löyttyniemi E, Liukko-Sipi S, Juhakoski A, Smal J, Laitinen K 1997 Pooling of clodronate urinary excretion data: A new pharmacokinetic method to study drugs with highly variable gastrointestinal absorption. J Bone Miner Res 12: 66-71
3. Conrad KA, Lee SM 1981 Clodronate kinetics and dynamics. Clin Pharmacol Ther 30: 114-120
4. Fleisch H 1991 Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone diseases. Drugs 42: 919-944
5. Gault MH, Longerich LL, Harnett JD, Wesolowski C 1992 Predicting glomerular function from adjusted serum creatinine. Nephron 62: 249-256
6. Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG 1995 Studies of the oral bioavalability of alendronate. Clin Pharmacol Ther 58: 288-298
7. Hanhijärvi H, Elomaa I, Karlsson M, Lauren L 1989 Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days. Int J Clin Pharmacol Ther 27: 602-606
8. Heikkinen JE, Selander KS, Laitinen K, Arnala I, Väänänen HK 1997 Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss. J Bone Miner Res 12: 103-110
9. Hyldstrup L, Flesch G, Hauffe SA 1993 Pharmacokinetic evaluation of pamidronate after oral administration: A study on dose proportionality, absolute bioavailability, and effect of repeated administration. Calcif Tissue Int 53: 297-300
10. Lin JH 1996 Bisphosphonates: A review of their pharmacokinetic properties. Bone 18: 75-85
11. O'Rourke NPO, McCloskey EV, Neugebauer G, Kanis JA 1994 Renal and nonrenal clearance of clodronate in patients with malignancy and renal impairment. Drug Invest 7: 26-33
12. Österman T, Lauren L 1991 Level of clodronate in bone after single and repeated subcutaneous injections in rats. Pharmacol Toxicol 69: 369-371
13. Pentikäinen PJ, Elomaa I, Nurmi A-K, Kärkkäinen S 1989 Pharmacokinetics of clodronate in patients with metastatic breast cancer. Int J Clin Pharmacol Ther 27: 222-228
14. Recker RR, Saville PD 1973 Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique. Toxicol Appl Pharmacol 24: 580-589
15. Saha HHT, Ala-Houhala IO, Liukko-Sipi SH, Ylitalo P, Pasternack AI 1998 Pharmacokinetics of clodronate in peritoneal dialysis patients. Perit Dial Int 18: 204-209
16. Saha H, Castren-Kortekangas P, Ojanen S, Juhakoski A, Tuominen J, Tokola O, Pasternack A 1994 Pharmacokinetics of clodronate in renal failure. J Bone Miner Res 9: 1953-1958
17. Sansom LN, Necciari J, Thiercelin JF 1995 Human pharmacokinetics of tiludronate. Bone 17 (Suppl 5): 479S-483S
18. Singer FR 1995 Bisphosphonates in the treatment disorders of mineral metabolism. Adv Endocrinol Metab 6: 259-288
19. Yakatan GJ, Poynor WJ, Talbert RL, Floyd BF, Slough CL, Ampulski RS, Benedict JJ 1982 Clodronate kinetics and bioavailability. Clin Pharmacol Ther 31: 402-410
20. Ylitalo R, Oksala O, Ylä-Herttuala S, Ylitalo P 1994 Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J Lab Clin Med 123: 769-776